Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984228 · ClinicalTrials.gov registry record · Phase 4
Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02984228 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 70 participants.
The verdict
NCT02984228, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study seeks to expand the current literature in demonstrating potentially efficacious, conservative treatments in the management of glenohumeral osteoarthritis (OA) and will compare ultrasound-guided injections of hyaluronic acid vs. platelet-rich plasma. We aim to obtain information measuring potential benefits of these interventions and to observe for any adverse events.
Interventions
- DEVICE Ultrasound
- BIOLOGICAL PRP
- DRUG Hyaluronic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02984228
The ClinicalTrials.gov registry entry for NCT02984228 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ultrasound is the first listed.
NCT02984228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02984228 about?
NCT02984228 is a clinical study titled "Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis". This study seeks to expand the current literature in demonstrating potentially efficacious, conservative treatments in the management of glenohumeral osteoarthritis (OA) and will compare ultrasound-guided injections of hyaluronic acid vs. platelet-rich plasma. We aim to obtain information measuring ...
What is the current status of trial NCT02984228?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2014-12. Estimated completion is 2020-11.
What interventions are being tested in trial NCT02984228?
The interventions under investigation include: Ultrasound (DEVICE), PRP (BIOLOGICAL), Hyaluronic Acid (DRUG).
Who is sponsoring clinical trial NCT02984228?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.